• Nenhum resultado encontrado

Prostate cancer – Therapy with radium-223

N/A
N/A
Protected

Academic year: 2019

Share "Prostate cancer – Therapy with radium-223"

Copied!
5
0
0

Texto

Loading

Imagem

FIGURE 2   Summary of the studies comparing the use of Ra223 versus placebo in the treatment of mCRPC regarding the outcome of number  of bone events.

Referências

Documentos relacionados

This retrospective outcome analysis of data from 1819 patients treated with either radical prostatectomy (RP), external beam radiation therapy (ERBT), or permanent

Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral

radiation therapy alone (mean: 47 days, median: 60 Figure 3 - Survival time of dogs with oral melanoma treated with adjuvant or palliative radiation. therapy according to

(14) evalu- ated 39 patients with prostate cancer (18 with an initial diagnosis before any therapy) and found that tracer uptake was more rapid and intense in areas of

To analyze the accuracy of the defining features of ND for fatigue in patients with breast cancer under radiation therapy

eventuais erros pré-analíticos e outros fatores interferen- tes mencionados, concluiu-se que se estava na presença do fenómeno de consumo de oxigénio pelos leucócitos

Methods: To determine the safety of CMV maintenance therapy withdrawal in patients with immune recovery after HAART, 35 patients with treated CMV retinitis, on maintenance

Neoadjuvant chemotherapy without routine use of radiation therapy for patients with locally advanced rectal cancer: a